Article info

Download PDFPDF
Experimental therapeutics: clinical
L05 Huntexil (pridopidine) improves voluntary motor function in patients with Huntington's disease: results from the phase 3 study MermaiHD

Citation

Squitieri F, Landwehrmeyer GB, Garcia de Yebenes J, et al
L05 Huntexil (pridopidine) improves voluntary motor function in patients with Huntington's disease: results from the phase 3 study MermaiHD

Publication history

  • First published November 16, 2010.
Online issue publication 
November 16, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.